AEG-33773

N/A

Report date: 2022/11/25 17:42:33

Base Information

Drug NameAEG-33773
Drug Alias NameAEG-33773
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 modulatorsHSP70 heat-shock proteins modulators
TargetsHeat shock protein HSP90HSP70 heat-shock proteins
Therapy Area/IndicationsDiabetic peripheral neuropathyChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAegera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAegera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetic peripheral neuropathyChronic Pain

Other Information

ATC CodeN/A
Related LinksN/A